Much of the marketing suggests that they’re safer than more traditional underarm products, but that hype is not based on science.
Most people will roll up their sleeves for the injection, but some may want to consider an alternate body part.
When Lisa Maksym tested positive for the coronavirus, she was forced to stop cancer treatments, threatening a long-planned return to Rome. Her sister hatched a plan.
A panel recommends biennial screenings, starting at 50, but a new study took issue with the way hundreds of centers are telling women 40 and up to come in yearly. Some experts contend that frequent mammograms can “do more harm than good.”
He was a top executive at Memorial Sloan Kettering before resigning over payments from health care companies. He went on to lead cancer research at AstraZeneca.
People have skipped their cancer screenings and ignored possible symptoms as a result of the pandemic. In some cases, the delay has come at a great cost.
In this year of sorrow, plunging into the water has been essential for me and for my friend with cancer.
As pandemic disruptions lead many of us to drink more, experts underscore the link between alcohol and disease.
The condition is becoming more common as immunization rates increase. Experts are suggesting ways to ease patients’ fears and avoid needless testing.
All this year, patients stayed away from doctors’ offices in droves, postponing tests and treatments. Maybe there’s a silver lining.
The danger of delayed screenings is greatest for people with known risk factors for cancer.
“Honesty is linear.” Relationships require work and redefining, year after year.
Does a pharmaceutical company have a moral obligation to acknowledge my participation with an ongoing supply of the product that I helped test?
Statin drugs, commonly prescribed for heart health, may prolong survival in some cancer patients.
Looking after two small kids while going through chemotherapy is the hardest thing I’ve ever done.
Because much cancer research and clinical trials have been based on white populations, efforts to explore the ways race and ethnicity influence disease are underway.
Some might be better off not knowing they have breast cancer because they are likely to die of other causes long before breast cancer would threaten their health.
The Cusp, a newly launched startup offering telemedicine services for women in perimenopause and menopause, is launching an at-home hormone test service that slashes the cost of in-office visits and lab tests.
Women in California can order the test at a cost of $159 for a telemedical consultation and test, versus roughly $500 for having the same test and lab work administered in a clinic, according to the company.
Unlike other, commonly-prescribed hormone tests The Cusp bases its still-to-be-clinically-validated test on new research that a key hormone measurement can help predict the time to menopause. The company is currently working with researchers to help the broader medical community validate these findings.
Although the test may not be clinically validated, the company said that its use of “menopause specialists” with specific training in issues surrounding perimenopause and menopause can provide a more complete diagnosis of a woman’s current state and what is likely to come next based on both clinical and laboratory data.
“Menopause is very stigmatized and midlife care is a highly underserved market. We launched The Cusp to provide women with a new model of care during this stage of life so women can optimize their health,” said The Cusp, chief executive, Taylor Sittler. “Our focus begins with perimenopause treatment as early care can lead to healthier outcomes.”
The company said that the test is best for women experiencing early signs of perimenopause, typically between the ages of 42 and 50.
“Throughout my career I’ve been focused on the intersection of women’s health, menopause, and breast cancer. It was shocking to me how little information is out there for women, so I worked with national committees helping establish guidelines for managing menopause symptoms and sexual functioning in cancer survivors,” said Dr. Mindy Goldman, Director of the Gynecology Center for Cancer Survivors and At-Risk Women Program at UCSF, and a physician working with The Cusp. “I’m thrilled to be a part of The Cusp, as we are on the front lines providing women with comprehensive diagnostic tools and personalized care so that menopause can be faced head-on and managed with a multi-pronged approach that can include medical interventions, naturopathic solutions, and/or hormone replacement therapies.”
The company is already providing care to roughly 75 patients already and is growing its membership rapidly. With its recent launch, The Cusp has joined startups like CurieMD, Elektra Health, and Geneve, which are all focused on providing medical services to women in perimenopause and menopause.
To date, the company has raised $4 million from investors including HomeBrew, Village Global and individual investors like Katie Stanton and Megan Pai.
Sittler, a co-founder of Color Genomics, sees an opportunity in applying new diagnostics tests and technology to treating women as they enter menopause.
The Cusp charges an initial $210 for tests and the first three months of care and then an additional monthly fee of $72 per month.
“Being able to provide these personalized solutions that involve proprietary technologies. We would love to get into newer treatments… once we get a few zeros to our member number… there’s an initial advantage that we have in terms of the integration we’ve already done and the advantages that we have,” said Sittler.
Ms. Preston was known for her role as a hardhearted fiancée of the Tom Cruise character in the 1996 film.
Being targeted by those who traffic in false promises feels like a “slap in the face” to patients like me.
As the coronavirus overwhelms the health care system, people with other illnesses struggle to find treatment.
The “Ordinary Love” actress reads an essay about breast cancer and the unexpected need for community.